Civil Servant Ultrasound Package (M/F)

US$498
NT$16,000 · you pay the hospital in NT$
Book this checkup

Prefer to book it yourself? Call Good Liver Health Management Center on 02-2388-8799 / 0800-000-582 or use its website ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-22

A premium-tier program with Abdominal ultrasound, Breast ultrasound, Carotid ultrasound, Pelvic (gynecologic) ultrasound and Prostate ultrasound and a 67-test panel.

Lead time
30 days
English report
Ask the hospital (we ask for you in Book it for me)

What stands out

Abdominal ultrasound

Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.

Breast ultrasound

Breast lumps; complements mammography, especially in dense breasts.

Carotid ultrasound

Plaque in the neck arteries; stroke risk.

Pelvic (gynecologic) ultrasound

Uterus and ovary abnormalities (fibroids, cysts).

Every test, in English

67 tests listed, 59 of them on our shared test list, so they line up against other hospitals' packages.

Vitals5
Blood Count3
Liver Function8
Kidney & Electrolytes6
Lipids & Cardiometabolic5
Glucose3
Thyroid & Endocrine2
Tumor Markers5
Infection Serology4
Urine & Stool3
Cardiac2
X-ray1
Ultrasound6
Women's Health2
Bone & Body Composition1
Eye3
Show all 67 tests and what each screens for
TestScreens forAdd-on?
Vitals
Blood pressureScreens for hypertension, a major risk factor for heart disease and stroke.Incl.
Body composition analysisBody fat, muscle mass and water percentage.Incl.
Height, weight and BMIBasic body measurements used to assess weight-related health risk.Incl.
Basic vital signs (pulse, temperature, respiration)Basic pulse, temperature and breathing rate measurements taken during a checkup.Incl.
Waist circumferenceCentral obesity, a marker of metabolic risk.Incl.
Blood Count
Antinuclear antibody (ANA)Autoimmune disease screening (e.g. lupus).Incl.
Complete blood countAnemia, infection and blood cell disorders.Incl.
White blood cell differentialBreakdown of white cell types; infection, allergy and some blood cancers.Incl.
Liver Function
AlbuminLiver function and nutrition status.Incl.
Alkaline phosphataseLiver, bile duct and bone conditions.Incl.
AmylasePancreatic or salivary gland enzyme; elevated levels can indicate pancreatitis.Incl.
Direct bilirubinBile duct obstruction.Incl.
Gamma-GTBile duct and alcohol-related liver stress.Incl.
Globulin and A/G ratioImmune protein levels.Incl.
LipasePancreatic enzyme; more specific than amylase for pancreatitis.Incl.
Total bilirubinJaundice, liver and bile problems.Incl.
Kidney & Electrolytes
Blood urea nitrogenKidney function.Incl.
CalciumBone, parathyroid and kidney conditions.Incl.
CreatinineKidney function.Incl.
Estimated GFRKidney filtering capacity; stages chronic kidney disease.Incl.
Electrolytes (Na, K, Cl)Salt and fluid balance; kidney and hormone problems.Incl.
Uric acidGout risk and kidney stone risk.Incl.
Lipids & Cardiometabolic
Total cholesterol / HDL ratioA calculated ratio of total cholesterol to HDL cholesterol used in some cardiovascular risk calculators.Incl.
HDL cholesterolProtective cholesterol level.Incl.
LDL cholesterolThe main cholesterol driving heart disease risk.Incl.
Total cholesterolCardiovascular risk.Incl.
TriglyceridesCardiovascular and pancreatitis risk.Incl.
Glucose
Fasting glucoseDiabetes and prediabetes.Incl.
Hemoglobin A1cAverage blood sugar over the past three months; diabetes.Incl.
Fasting insulinInsulin resistance.Incl.
Thyroid & Endocrine
Free T4Thyroid hormone level.Incl.
TSHThyroid function; the primary thyroid screening test.Incl.
Tumor Markers
AFPLiver cancer marker (also used with liver ultrasound in hepatitis B carriers).Incl.
CA-125Ovarian cancer marker.Incl.
CA 19-9Pancreatic and biliary cancer marker.Incl.
CEAColorectal and other GI cancer marker.Incl.
PSAProstate cancer marker.Incl.
Infection Serology
Hepatitis B surface antibodyImmunity to hepatitis B (from vaccine or past infection).Incl.
Hepatitis C antibodyHepatitis C infection.Incl.
H. pylori urea breath testActive H. pylori infection.Incl.
Hepatitis B surface antigenCurrent hepatitis B infection; very common in Taiwan.Incl.
Urine & Stool
Stool occult blood (FIT)Colorectal cancer and polyps; the standard non-invasive colon screen.Incl.
UrinalysisKidney disease, urinary infection, diabetes.Incl.
Urine microalbumin / ACREarly kidney damage, especially in diabetes and hypertension.Incl.
Cardiac
10-year cardiovascular risk scoreA calculated estimate of your 10-year risk of heart attack or stroke based on your risk factors.Incl.
Resting ECGHeart rhythm and signs of prior heart damage.Incl.
X-ray
Chest X-rayLung, heart size and chest abnormalities.Incl.
Ultrasound
Abdominal ultrasoundLiver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.Incl.
Breast ultrasoundBreast lumps; complements mammography, especially in dense breasts.Add-on
Carotid ultrasoundPlaque in the neck arteries; stroke risk.Incl.
Pelvic (gynecologic) ultrasoundUterus and ovary abnormalities (fibroids, cysts).Incl.
Prostate ultrasoundProstate size and abnormalities.Incl.
Thyroid ultrasoundThyroid nodules.Incl.
Women's Health
MammographyBreast cancer; the standard screen for women 40+.Add-on
Pap smearCervical cancer and precancer.Incl.
Bone & Body Composition
Bone density (DXA)Osteoporosis and fracture risk.Incl.
Eye
Retinal (fundus) photographyDiabetic and hypertensive eye damage, macular degeneration.Incl.
Intraocular pressureGlaucoma.Incl.
Visual acuityVision sharpness.Incl.
Vitals
Blood pressureIncl.
Screens for hypertension, a major risk factor for heart disease and stroke.
Body composition analysisIncl.
Body fat, muscle mass and water percentage.
Height, weight and BMIIncl.
Basic body measurements used to assess weight-related health risk.
Basic vital signs (pulse, temperature, respiration)Incl.
Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumferenceIncl.
Central obesity, a marker of metabolic risk.
Blood Count
Antinuclear antibody (ANA)Incl.
Autoimmune disease screening (e.g. lupus).
Complete blood countIncl.
Anemia, infection and blood cell disorders.
White blood cell differentialIncl.
Breakdown of white cell types; infection, allergy and some blood cancers.
Liver Function
AlbuminIncl.
Liver function and nutrition status.
Alkaline phosphataseIncl.
Liver, bile duct and bone conditions.
AmylaseIncl.
Pancreatic or salivary gland enzyme; elevated levels can indicate pancreatitis.
Direct bilirubinIncl.
Bile duct obstruction.
Gamma-GTIncl.
Bile duct and alcohol-related liver stress.
Globulin and A/G ratioIncl.
Immune protein levels.
LipaseIncl.
Pancreatic enzyme; more specific than amylase for pancreatitis.
Total bilirubinIncl.
Jaundice, liver and bile problems.
Kidney & Electrolytes
Blood urea nitrogenIncl.
Kidney function.
CalciumIncl.
Bone, parathyroid and kidney conditions.
CreatinineIncl.
Kidney function.
Estimated GFRIncl.
Kidney filtering capacity; stages chronic kidney disease.
Electrolytes (Na, K, Cl)Incl.
Salt and fluid balance; kidney and hormone problems.
Uric acidIncl.
Gout risk and kidney stone risk.
Lipids & Cardiometabolic
Total cholesterol / HDL ratioIncl.
A calculated ratio of total cholesterol to HDL cholesterol used in some cardiovascular risk calculators.
HDL cholesterolIncl.
Protective cholesterol level.
LDL cholesterolIncl.
The main cholesterol driving heart disease risk.
Total cholesterolIncl.
Cardiovascular risk.
TriglyceridesIncl.
Cardiovascular and pancreatitis risk.
Glucose
Fasting glucoseIncl.
Diabetes and prediabetes.
Hemoglobin A1cIncl.
Average blood sugar over the past three months; diabetes.
Fasting insulinIncl.
Insulin resistance.
Thyroid & Endocrine
Free T4Incl.
Thyroid hormone level.
TSHIncl.
Thyroid function; the primary thyroid screening test.
Tumor Markers
AFPIncl.
Liver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125Incl.
Ovarian cancer marker.
CA 19-9Incl.
Pancreatic and biliary cancer marker.
CEAIncl.
Colorectal and other GI cancer marker.
PSAIncl.
Prostate cancer marker.
Infection Serology
Hepatitis B surface antibodyIncl.
Immunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibodyIncl.
Hepatitis C infection.
H. pylori urea breath testIncl.
Active H. pylori infection.
Hepatitis B surface antigenIncl.
Current hepatitis B infection; very common in Taiwan.
Urine & Stool
Stool occult blood (FIT)Incl.
Colorectal cancer and polyps; the standard non-invasive colon screen.
UrinalysisIncl.
Kidney disease, urinary infection, diabetes.
Urine microalbumin / ACRIncl.
Early kidney damage, especially in diabetes and hypertension.
Cardiac
10-year cardiovascular risk scoreIncl.
A calculated estimate of your 10-year risk of heart attack or stroke based on your risk factors.
Resting ECGIncl.
Heart rhythm and signs of prior heart damage.
X-ray
Chest X-rayIncl.
Lung, heart size and chest abnormalities.
Ultrasound
Abdominal ultrasoundIncl.
Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Breast ultrasoundAdd-on
Breast lumps; complements mammography, especially in dense breasts.
Carotid ultrasoundIncl.
Plaque in the neck arteries; stroke risk.
Pelvic (gynecologic) ultrasoundIncl.
Uterus and ovary abnormalities (fibroids, cysts).
Prostate ultrasoundIncl.
Prostate size and abnormalities.
Thyroid ultrasoundIncl.
Thyroid nodules.
Women's Health
MammographyAdd-on
Breast cancer; the standard screen for women 40+.
Pap smearIncl.
Cervical cancer and precancer.
Bone & Body Composition
Bone density (DXA)Incl.
Osteoporosis and fracture risk.
Eye
Retinal (fundus) photographyIncl.
Diabetic and hypertensive eye damage, macular degeneration.
Intraocular pressureIncl.
Glaucoma.
Visual acuityIncl.
Vision sharpness.
Also listed: ALT (GPT), AST (GOT), Basic hearing test, Health checkup physical examination, Hepatitis A antibody (Anti-HAV IgG), Metabolic syndrome screening, Urine chemistry panel, Urine protein.

Before you book

Booking lead time30 days
If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.
Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.
Good Liver Health Management Center
Taipei · Zhongzheng

10 packages listed

About this hospital

What the center says

From the center's own pages, in English. Each statement links to its source.

Booking and payment
  • The center recommends booking the health checkup at least one month before the desired exam date.

    Source ↗ · checked 2026-09-22

  • A patient who wants to switch to a different checkup package must tell the center at least 7 days before the exam.

    Source ↗ · checked 2026-09-22

  • Rescheduling or cancelling a high-end imaging exam (CT or MRI) must be requested at least 7 working days before the exam date.

    Source ↗ · checked 2026-09-22

  • If the pre-checkup packet and bowel-prep medication have already been mailed out, cancelling the checkup afterward means the center charges for the bowel-prep medication.

    Source ↗ · checked 2026-09-22

  • On the day of the checkup, patients can pay by cash or credit card.

    Source ↗ · checked 2026-09-22

Before and on the day
  • After booking, patients must complete an online health questionnaire before checking in at the center, submitting it by clicking Submit to finish.

    Source ↗ · checked 2026-09-22

  • The center says only fasting blood glucose, cholesterol and triglyceride tests require fasting; other tests do not require strict fasting, and a moderate amount of plain water is allowed during the fasting period.

    Source ↗ · checked 2026-09-22

Results
  • As of 2026-02-01, the center no longer automatically provides an image CD for in-house exam items; if a patient needs one for a visit to another clinic, they can call to request one, which is provided free of charge.

    Source ↗ · checked 2026-09-22

  • For high-end imaging done at partner hospitals (such as CT or MRI), the center always provides the full image CD along with a paper report.

    Source ↗ · checked 2026-09-22

  • The center gives patients a full paper report and also offers its own app, where patients can see the complete report, view imaging pictures with the physician's English-language interpretation for imaging studies, and download the whole report as a PDF.

    Source ↗ · checked 2026-09-22

Add to this package

Tests this center prices separately that this package does not include.

TestPriceNote
Rheumatoid factor (RF)as listed: Rheumatoid factor
US$11
NT$350
Iron studiesas listed: Iron studies (serum iron, ferritin, TIBC)
US$28
NT$900
serum iron, ferritin, TIBC
High-sensitivity CRPas listed: High-sensitivity C-reactive protein (hs-CRP)
US$16
NT$500
Homocysteine
US$25
NT$800
Vitamin D (25-OH)as listed: Vitamin D test
US$29
NT$920
CA 15-3as listed: CA 15-3 tumor marker
US$19
NT$600
For women
Hepatitis A antibodyas listed: Hepatitis A antibody (anti-HAV IgG)
US$11
NT$350
H. pylori stool antigenas listed: Stool H. pylori antigen test
US$16
NT$500
Hepatitis A antibodyas listed: Acute hepatitis A antibody (HAV-IgM)
US$16
NT$500
Echocardiogramas listed: Cardiac color Doppler ultrasound (echocardiogram)
US$125
NT$4,000
Spine X-rayas listed: Cervical spine X-ray (AP + lateral)
US$19
NT$600
Liver elastography (FibroScan)as listed: Liver fibrosis scan (FibroScan)
US$37
NT$1,200

Source ↗ · checked 2026-09-22

US price context

Bought one by one at US cash-pay marketplaces, the tests we could price list at about US$2,872–4,017 for a woman (55 of 55 tests) and US$3,236–4,281 for a man (54 of 54 tests) (MDsave, Quest and others; checked 2026-10-11).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

Radiation from this package's imaging

About 0.1 mSv from the tests we could identify, a typical adult dose for these exams: less than 1 month of natural background radiation (about 3 mSv a year, US average).

This package also lists 8 items we have not matched to a test; if any of them is an X-ray, CT or PET scan, the total is higher.

  • Bone density (DXA) · about less than 0.01 mSv
  • Chest X-ray · about 0.1 mSv

Optional add-ons would add: Mammography (about 0.28 mSv).

Typical doses from published references (RadiologyInfo.org ↗, Mettler et al. 2008 ↗); the actual dose depends on the scanner and protocol. Ask the center for its own figure.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 27 of these tests
Recommended (grade A/B)The USPSTF recommends screening all adults aged 18 to 79 years for hepatitis C virus infection. (2020) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for hypertension in adults 18 years or older with office blood pressure measurement, confirmed with measurement outside the clinical setting before starting treatment. (2021) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in postmenopausal women younger than 65 years who are at increased risk, based on a clinical risk-assessment tool. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for osteoporosis in men. (2025) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in women 65 years or older. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of supplemental screening with breast ultrasound in women found to have dense breasts on an otherwise negative screening mammogram. (2024) · USPSTF ↗ Note: Same I statement covers ultrasound and MRI as supplemental tests; see mri_breast. The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with the CA-125 blood test. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers CA-125 and transvaginal/pelvic ultrasound; see pelvic_ultrasound.
Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The recommendation states there are currently no accurate, validated biomarkers for early detection of pancreatic cancer and that the USPSTF does not recommend screening the general population by any method; it does not name CA 19-9. The D grade applies to screening this population by any method, not to CA 19-9 as a separately graded test. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.
Recommended against (grade D)The USPSTF recommends against screening for asymptomatic carotid artery stenosis in the general adult population. (2021) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for calculating the score. The USPSTF tells clinicians to estimate 10-year cardiovascular risk with a risk estimator (it names the ACC/AHA Pooled Cohort Equations) as a step in the statin decision. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for calculating the score. The USPSTF tells clinicians to estimate 10-year cardiovascular risk with a risk estimator (it names the ACC/AHA Pooled Cohort Equations) as a step in the statin decision. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for calculating the score. The USPSTF tells clinicians to estimate 10-year cardiovascular risk with a risk estimator (it names the ACC/AHA Pooled Cohort Equations) as a step in the statin decision. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for primary open-angle glaucoma in adults. (2022) · USPSTF ↗ Note: Same I-statement covers tonometry (intraocular pressure), optic-nerve/fundus imaging and OCT as candidate glaucoma-screening methods.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Recommended (grade A/B)The USPSTF recommends screening for hepatitis B virus infection, with an HBsAg test followed by confirmatory testing, in adolescents and adults at increased risk for infection. (2020) · USPSTF ↗ Note: Risk groups include people born in a country with HBV prevalence of 2% or more, US-born people not vaccinated as infants whose parents were born in regions with very high HBV prevalence (8% or more), people with HIV, people who inject drugs, men who have sex with men, and household or sexual contacts of someone with HBV. The recommendation names regions by prevalence, not countries.
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Recommended (grade A/B)The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 or higher to intensive, multicomponent behavioral weight-loss interventions. (2018; an update is in progress) · USPSTF ↗ Note: The grade applies to offering or referring adults with a BMI of 30 or higher to intensive behavioral weight-loss programs, not to measuring height, weight or BMI; the USPSTF says screening for obesity is now part of routine clinical practice and was not a focus of its review. The USPSTF lists an update in progress, folded into a combined topic on healthy diet, physical activity and weight loss to prevent cardiovascular disease; the 2018 statement remains the current final recommendation as of 2026-09-25.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for primary open-angle glaucoma in adults. (2022) · USPSTF ↗ Note: Same I-statement covers tonometry (intraocular pressure), optic-nerve/fundus imaging and OCT as candidate glaucoma-screening methods.
Recommended (grade A/B)The USPSTF recommends biennial screening mammography for women aged 40 to 74 years. (2024) · USPSTF ↗ Note: The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening mammography in women 75 years or older. (2024) · USPSTF ↗ Note: The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women younger than 21 years. (2018; an update is in progress) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (CIN 2 or 3) or cervical cancer. (2018; an update is in progress) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29 years. (2018; an update is in progress) · USPSTF ↗ Note: A draft update was posted December 10, 2024 (public comment to January 13, 2025); not yet a new final recommendation as of 2026-09-25.
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer in women aged 30 to 65 years, every 3 years with cytology alone, every 5 years with high-risk HPV testing alone, or every 5 years with HPV testing combined with cytology. (2018; an update is in progress) · USPSTF ↗ Note: A draft update was posted December 10, 2024 (public comment to January 13, 2025); not yet a new final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women older than 65 years who have had adequate prior negative screening and are not otherwise at high risk. (2018; an update is in progress) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with transvaginal ultrasound. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers pelvic/transvaginal ultrasound and the CA-125 blood test; see ca125. This csv does not map pelvic_ultrasound to any recommendation about non-ovarian pelvic findings (fibroids, cysts), which the USPSTF does not address.
Selective (grade C)The USPSTF says the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one for men aged 55 to 69 years. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against PSA-based screening for prostate cancer in men 70 years or older. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening with resting or exercise ECG to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening with resting or exercise ECG to prevent cardiovascular disease events in adults at intermediate or high risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for atrial fibrillation with ECG in adults 50 years or older. (2022) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years, including with an annual stool test for occult blood (FIT or high-sensitivity gFOBT). (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in all adults aged 50 to 75 years, including with an annual stool test for occult blood (FIT or high-sensitivity gFOBT). (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Selective (grade C)The USPSTF recommends that clinicians selectively offer colorectal cancer screening, including with an annual stool test for occult blood (FIT or high-sensitivity gFOBT), to adults aged 76 to 85 years based on overall health, prior screening history and the patient's preferences. (2021) · USPSTF ↗ Note: Grade C reflects an individual decision rather than a blanket recommendation for or against. Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Recommended against (grade D)The USPSTF recommends against screening for thyroid cancer in asymptomatic adults. (2017) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for bladder cancer in asymptomatic adults. (2011) · USPSTF ↗ Note: The USPSTF lists urine dipstick or microscopic urinalysis for hematuria (blood in the urine) among the bladder cancer screening tests it considered. This note covers only that use of a urinalysis.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for impaired visual acuity in older adults. (2022) · USPSTF ↗
General preparation notes for 16 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Body composition analysis

Mention when booking: Mention a pacemaker or implanted defibrillator: the test passes a weak electric current through the body and has traditionally not been recommended with these devices.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Triglycerides

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Fasting insulin

Usually needs 8 to 12 hours of fasting (no food or drink except plain water) beforehand.

Mention when booking: Mention biotin (vitamin B7) supplements, usually paused for at least a day before this test, and any diabetes medicine; ask the prescribing doctor before changing any medicine.

H. pylori urea breath test

Usually needs several hours without food or drink beforehand. Antibiotics, bismuth and acid-reducing PPIs taken in the weeks before can hide the infection, so the center will ask about them.

Mention when booking: Tell the center which antibiotics, bismuth products or acid-reducing medicines you take, and ask the prescribing doctor about timing before the test.

Stool occult blood (FIT)

Guaiac-based kits usually ask you to avoid red meat, NSAIDs and more than 250mg of vitamin C for a few days beforehand; FIT kits usually need no diet change.

Mention when booking: Tell the center which kit you were given, and ask the prescribing doctor before stopping aspirin taken for the heart.

Urinalysis

Usually needs a clean-catch (midstream) sample; some tests instead ask you to collect all urine passed over 24 hours.

Mention when booking: Ask which specific urine test your provider ordered, since collection instructions vary by test.

Chest X-ray

Usually needs no fasting; you remove jewelry, metal objects and sometimes clothing above the waist for a hospital gown.

Mention when booking: Tell the center if you are, or might be, pregnant.

Abdominal ultrasound

Usually needs about 6 hours without food beforehand; clear fluids other than milk or fizzy drinks are commonly still allowed. Loose, comfortable clothing is easiest.

Mention when booking: Mention if you have type 1 diabetes, so the center can offer an early appointment time.

Pelvic (gynecologic) ultrasound

For a transabdominal scan, drinking water beforehand to fill the bladder is common; for a transvaginal scan, an empty bladder is usual instead.

Mention when booking: Tell the center which type of scan you expect, and mention if you are, or might be, pregnant.

Prostate ultrasound

Usually needs little or no preparation; an enema and antibiotics are mainly for a planned biopsy. A scan through the lower belly instead may need a full bladder.

Mention when booking: Mention aspirin or other blood thinners; if a biopsy is planned, the center may ask about pausing them, so ask the prescribing doctor before changing any medicine.

Pap smear

Usually asks that you avoid intercourse, douching and tampons for 24 hours beforehand, and avoid scheduling during your period if possible.

Mention when booking: Tell the center if you are having unexpected bleeding, think you might be pregnant, or have had an abnormal Pap or positive HPV test before.

Afterwards: Light bleeding or spotting afterward is common and usually stops within a few hours.

Mammography

Usually asks that you skip deodorant, powder or lotion on the underarms and breasts, since these can look like calcium spots on the image. Bring prior mammograms from elsewhere if you have them.

Mention when booking: Mention breast implants, any breast symptoms, prior breast surgery, hormone use, or the possibility of pregnancy.

Afterwards: You may be asked to wait until the radiologist confirms the images are complete; ask when to expect results.

Bone density (DXA)

Usually asks that you skip calcium supplements for 24 hours beforehand. Avoid clothing with metal zippers or buttons, and remove jewelry.

Mention when booking: Mention any recent barium exam or CT/nuclear-medicine contrast, and whether pregnancy is possible.

Retinal (fundus) photography

Often done with a camera that photographs the retina without drops; some centers use dilating drops that widen the pupil, which blurs vision for a few hours afterward.

Mention when booking: Mention any eye pain, halos around lights, or a narrow drainage angle or angle-closure glaucoma history.

Afterwards: If drops were used, vision may be blurry and light-sensitive for a few hours; have someone else drive. Sudden eye pain, headache, blurred vision or halos after dilation need urgent care.

Sources
As published by the hospital · checked 2026-09-22

How we collect and check these prices: see who we are and where the data comes from.

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.
Package name translated by us from the hospital's Chinese name.
Civil Servant Ultrasound Package (M/F)
US$498
Book this checkup

If this isn't quite right

Other packages at Good Liver Health Management Center

All packages at Good Liver Health Management Center →

Similar packages in Taipei

Same tier, other hospitals in Taipei, closest in price first.
PackageHospitalTestsPrice
Advanced PackageCountry Hospital70
US$498
NT$16,000
Premium Class Health CheckupPojen General Hospital59
US$498
NT$16,000
Whole-Body Health Checkup (NT$15,000/16,000 Plan)Chung Shan Hospital (Taipei)58
US$467
NT$15,000
Women US$498
Basic Imaging CheckupCathay General Hospital Health Management Center60
US$561
NT$18,000
Lung Cancer Prevention PackageCountry Hospital67
US$623
NT$20,000

All checkups in Taipei →

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.

Browse: Cancer screening · All checkups in Taipei · What a checkup costs in Taiwan